Which has the lower trailing P/E, KR or MEDP?

KR has the lower trailing P/E: KR trades at 34.20 and MEDP at 34.42. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, KR or MEDP?

Over the past five years, MEDP grew revenue faster — KR at a 2.33% CAGR versus MEDP at 22.03%.

Does KR or MEDP pay a bigger dividend?

KR pays a dividend (2.55% yield), while MEDP has no payments in the available dividend history.

Is KR or MEDP more profitable?

MEDP runs the higher net margin — KR at 0.71% versus MEDP at 17.67%.

How have KR and MEDP total returns compared?

Over the past 10 years, KR delivered 8.24% and MEDP delivered 34.74% annualized total return. Past performance doesn't predict future results.

The Kroger Co. (KR) vs Medpace Holdings, Inc. (MEDP)

A side-by-side comparison of The Kroger Co. and Medpace Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

Different business models: KR is classified in Consumer Defensive; MEDP is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

The Kroger Co.

$35.83B

$58.49Consumer DefensiveDelayed quote: Sep 11, 2026, 4:00 PM EDT

MEDP

Medpace Holdings, Inc.

$16.40B

$587.52HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — KR vs MEDP

growth of $100 · dividends reinvested · last 10y

KR +112.9% (+7.8%/yr)MEDP +1870.8% (+34.7%/yr)MEDP compounded faster over this window

Log scale — wide-divergence pair

KR MEDP

KR vs MEDP: by the numbers

•KR is the larger company ($35.83B vs $16.40B market cap).
•KR trades at the lower trailing earnings multiple (34.20 vs 34.42 P/E), one valuation lens rather than an overall verdict.
•MEDP converts more revenue to profit (17.67% vs 0.71% net margin).
•MEDP grew revenue faster over the past five years (22.03% vs 2.33% CAGR).
•KR pays a dividend (2.55% yield), while MEDP has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	KR	MEDP
P/E ratio	34.20	34.42
Forward P/E	11.26	33.38
P/S ratio	0.24	5.89
P/B ratio	5.54	37.80
EV / EBITDA	10.47	26.20
FCF yield	8.05%	4.28%

Profitability

Metric	KR	MEDP
Gross margin	23.18%	28.76%
Operating margin	1.33%	20.97%
Net margin	0.71%	17.67%
ROE	16.27%	113.29%
ROIC	4.89%	77.00%

Dividends

Metric	KR	MEDP
Dividend yield	2.55%	N/A
Payout ratio	84.21%	N/A

Growth (annualized)

Metric	KR	MEDP
Revenue CAGR (5Y)	2.33%	22.03%
EPS CAGR (5Y)	-13.96%	30.90%
FCF CAGR (5Y)	-1.62%	23.40%
Total return CAGR (5Y)	6.39%	24.92%

Frequently asked

Which has the lower trailing P/E, KR or MEDP?: KR has the lower trailing P/E: KR trades at 34.20 and MEDP at 34.42. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, KR or MEDP?: Over the past five years, MEDP grew revenue faster — KR at a 2.33% CAGR versus MEDP at 22.03%.
Does KR or MEDP pay a bigger dividend?: KR pays a dividend (2.55% yield), while MEDP has no payments in the available dividend history.
Is KR or MEDP more profitable?: MEDP runs the higher net margin — KR at 0.71% versus MEDP at 17.67%.
How have KR and MEDP total returns compared?: Over the past 10 years, KR delivered 8.24% and MEDP delivered 34.74% annualized total return. Past performance doesn't predict future results.

Go deeper

Full KR analysis Full MEDP analysis Interactive comparison tool

Dig into the metrics

Kroger P/E ratio Medpace P/E ratio Kroger dividend yield Kroger ROE Medpace ROE Kroger operating margin Medpace operating margin Kroger revenue growth Medpace revenue growth Kroger free cash flow Medpace free cash flow

Kroger & Medpace appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.